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FluKB is a knowledge-based system focusing on data and analytical tools for influenza vaccine discovery. The main goal of FluKB
is to provide access to curated influenza sequence and epitope data and enhance the analysis of influenza sequence diversity and
the analysis of targets of immune responses. FluKB consists of more than 400,000 influenza protein sequences, known epitope
data (357 verified T-cell epitopes, 685 HLA binders, and 16 naturally processed MHC ligands), and a collection of 28 influenza
antibodies and their structurally defined B-cell epitopes. FluKB was built using a modular framework allowing the implementation
of analytical workflows and includes standard search tools, such as keyword search and sequence similarity queries, as well as
advanced tools for the analysis of sequence variability. The advanced analytical tools for vaccine discovery include visual mapping
of T- and B-cell vaccine targets and assessment of neutralizing antibody coverage. FluKB supports the discovery of vaccine targets
and the analysis of viral diversity and its implications for vaccine discovery as well as potential T-cell breadth and antibody cross
neutralization involving multiple strains. FluKB is representation of a new generation of databases that integrates data, analytical
tools, and analytical workflows that enable comprehensive analysis and automatic generation of analysis reports.
1. Introduction
An estimated 250,000–500,000 people die from seasonal
influenza infection each year. The economic impact of
influenza is immense due to the large number of lost work-
ing hours, hospitalizations, further medical complications,
and treatment costs. Although vaccines against influenza
exist, the rapid mutation of influenza virus calls for con-
stant surveillance and annual vaccine reformulation [1]. A
huge body of sequence data, annotations, and knowledge
is available in the literature, online resources, and biolog-
ical databases such as GenBank [2], UniProt [3], Protein
Data Bank [4], EpiFlu Database [5], OpenFlu Database [6],
Influenza Research Database (IRD) [7], and the Immune
EpitopeDatabase (IEDB) [8].However, the underlyingmech-
anisms of host/pathogen interaction are still not completely
understood. The lack of a “universal” or broadly neutral-
izing influenza vaccine can be attributed to, among other
factors, combinatorial complexity of the host immune system
and the highly variable nature of viral antigens leading to
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immune escape of the emerging influenza variants [9, 10].
One approach, in an attempt to overcome challenges of
immune escape, is to raise a T-cell response against class I
or class II epitopes conserved among viral strains [11, 12].
Public databases represent valuable resource for the study
and development of broadly protective T-cell vaccines, but
our ability to analyze these data falls behind the pace of data
accumulation.
Numerous computational analysis tools that are useful for
vaccine target discovery are available. They include keyword
and text search tools, sequence comparison tools such as the
BLAST algorithm [13] or multiple sequence alignment tools
such as MAFFT [14], MUSCLE [15], and the Clustal [16], 3D
structure visualization tools [17, 18], HLA binding prediction
algorithms [19–21], and conservation analysis tools [22, 23],
among others. The application of these tools in discrete
steps can yield valuable information; however the extraction
of higher-level knowledge requires integrating data from
multiple databases and employing various analytical tools
to answer specific questions. For example, when a new
infectious influenza strain emerges (such as H9N7 avian
flu [24] or a new seasonal flu) it is desirable to rapidly
investigate its similarities and dissimilarities with known
sequences, its epidemic or pandemic potential in humans,
how different it is from the past vaccine strains, and its T-
and B-cell epitopes from previously circulating strains and
estimate its immune escape potential. Additionally, for new
pandemic strains (such as 2009 swine flu [25]) it is desirable
to establish origin and identify strains that are useful vaccine
candidates. Well-defined workflows enable rapid extraction
of such knowledge and automated generation of reports
that contain such information, for which knowledge-based
systems have previously been utilized [26, 27]. The need
for integration and advanced analysis of available data is
rapidly increasing. The integration of multistep analysis of
multidimensional data for vaccine analysis and discovery
requires the automation of analytical workflows [28].
FluKB is a knowledge-based system that integrates mul-
tiple types of influenza data and analytical tools into such
workflows to support vaccine target discovery. The datasets
in FluKB consist of curated, enriched, and standardized
protein sequence data, immunological data from multiple
data sources, and a set of modular analysis tools. The
analysis tools infrastructure comprises a library of individual
tools along with standard (applicable to multiple pathogens)
and specific influenza vaccine target discovery workflows.
Furthermore, we developed a standardized nomenclature to
enable and speed up datamining using automatedworkflows.
FluKB has a user-friendly web-based interface to access the
data, tools, predefined workflows, and workflow reports. The
overall architecture of FluKB is shown in Figure 1.
2. Materials and Methods
2.1. KB-Builder. FluKB was implemented using the KB-
builder framework [29]. Briefly, KB-builder consists of seven
major functional modules that enable automated data extrac-
tion frommultiple sources, data cleaning, import to a central
repository, integration of basic analysis tools, integration of
advanced analysis tools, workflow definition, and update
andmaintenance.TheKB-builder framework enabled setting
up a web-accessible knowledge base and the analysis work-
flows. A workflow takes the user request, performs complex
analyses which combines specific data and analytical tools,
and feeds the results into subsequent analyses to produce a
comprehensive report. The web-accessible interface uses a
set of graphical user interface forms. These interfaces access
search routines, analytical tools, and workflows that use
a combination of PHP, Perl, Common Gateway Interface
(CGI), and C background software. Development of KB-
build and FluKB was carried out in CentOS 5.11 Linux
environment. The web server used is Apache HTTP server
2.2.3 so the access to the web server is per default parallelized
for each user. The Linux server is a 16-core server with 32GB
ram and should be able to handle the traffic to the website.
2.2. Data Sources for FluKB Data Repository. The data repos-
itory within FluKB contains four types of data: protein
sequence data, HLA-related data (T-cell epitopes and HLA
ligands), 3D crystal structures, and neutralizing antibody-
related data. Protein sequences available from Influenza A,
B, and, C viruses were collected from IRD [7] and GenBank
[2], while HLA-related data were collected from IEDB [8].
The complex structures of neutralizing antibodies against
influenza virus hemagglutinin (HA) were collected from the
Protein Databank (PDB) [4]. The binding and neutralization
assays of each neutralizing antibody were collected from
primary literature, as described in [30].
2.3. Data Collection, Cleaning, and Enrichment
2.3.1. Protein Data Entries and Their Updates. The following
sequence data and annotations were extracted from the IRD:
protein sequence, GenBank identifiers (GI and Accession
Numbers), UniProt ID, and nomenclature (type, host, loca-
tion, ID, year, and subtype) when available. The metadata
included a vocabulary that comprises the instances of the
following terms: protein names, host names, geographic
locations, years, and subtypes. The vocabulary was generated
from the collected entries and enriched using primary lit-
erature. The vocabulary comprised correct terms as well as
variants of the terms, and erroneous terms. During updates,
each new entry is checked against the list of correct and
erroneous terms. If all terms within the entry are matched
to the correct terms, the entry is automatically annotated
and converted into the FluKB format. If an erroneous term
is identified, the curator is alerted and the correct term
is proposed for the entry. The curator then approves the
change or manually corrects the entry and updates the
vocabulary, when needed. Each new term identified in the
update dataset is inspected by the curator and added to the
vocabulary. The vocabulary iteratively increases in size with
each update and less than 20 new terms are usually identified
for each update. This approach enables data curation that
is of extremely high quality and can be performed very
fast (Figure 2 upper path). We converted existing nomen-
clatures, whenever possible, into standardized formats. To
verify the protein annotations of newly added entries, protein
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Figure 1: Overview of the architecture of FluKB. (a) Users can access FluKB through an interactive user interface where they can select
specific data and tools or deploy a predefined workflow. (b) Top to bottom: data are collected, cleaned, and enriched. Higher-level knowledge
extraction is enabled by utilization of tools assembled into workflows.
assignment of the strain proteomes was done by aligning
the entry proteome sequence to a representative influenza
reference sequences using the BLAST algorithm.We selected
10 proteins from UniProt that have detailed annotations as
reference sequences for each protein of the two influenza
types (A and B). The reference sequences are shown in
Supplemental Table S1 (see Supplementary Material available
online at http://dx.doi.org/10.1155/2015/380975).
2.3.2. Immunological Data. The immunological data
extracted from IEDB include T-cell epitope sequence,
epitope type (HLA binding, naturally processed, or T-cell
epitope), PubMed references, experimental methods and
results, and HLA-allele restriction (Figure 2 lower path).
FluKB includes entries from IEDB that bind HLA class I or
II allele with at least one positive result, or those reported as
T-cell epitopes.
2.3.3. Neutralizing Antibody Data. For each neutralizing
antibody, the following descriptive information is provided
in the FluKB: isolation information (from human samples
or from antibody phage-display libraries) from the primary
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Figure 2: Semiautomated generation and updating of protein sequence repository of FluKB (upper path) and data extraction and repository
creation of the influenza specific epitopes from IEDB (lower path).
literature, the corresponding crystal structure of antibody-
HA complex from the PDB database, the B-cell epitope
sequence variants detected from experimentally validated
strains, and computationally defined B-cell epitopes on HA
protein displayed as both sequence and 3D structure with
Jmol [31].
2.4. InfluenzaNomenclature Standardization andDefinition of
DataMining Keys. Each influenza strain sample is annotated
using the nomenclature originally proposed by the WHO
[32] providing a shorthand description of influenza virus
strains. However, the lack of a standardized vocabulary has
made these nomenclatures error prone. For example, the
nomenclature of an influenza isolate of type A, subtype
H2N3, isolated from a duck inHeinersdorf in 1986, is written,
using the original nomenclature as
A/Peking duck/Heinersdorf/648-4/1986(H2N3)
The lack of standardization of nomenclature has led to
inconsistent nomenclature and incomplete metadata, thus
increasing the difficulty in extraction of specific data subsets
for analysis.The nomenclature in the Heinersdorf 1986 strain
648-4 has two issues. First the organism name term is
erroneous (“Peking duck” is a traditional Chinese dish, while
“Pekin duck” is the organism). Second, it is unclear where
Heinersdorf is located. To ensure a complete access control
over the sequence data within FluKB each entry was given a
standardized data mining key.This key converts the nonstan-
dardizednomenclature fields into a fully standardized format.
The key is represented in FluKB as a standardized FASTA
header that provides a condensed and detailed summary of
the sample’s information. The FluKB data mining key for the
Heinersdorf sample HA protein is
>FLU0175850|type:A|host:/Mallard;Anas
platyrhynchos;8839|location:Heinersdorf;Berlin-
Germany;DE-BE|isolate:648-4|year:1986|subtype:
H2N3|protein:HA|seqtype:complete|variant:1|
vaccine: |genbank: CY117179|geneinfo:
386644010|uniprot: |original: A/Peking duck/
Heinersdorf/648-4/1986|key:yes
This search key compresses detailed sequence annota-
tions into the FASTA format enabling easy combination
of the results of sequence comparison with the analysis
of annotations. Standardized formats for host and geo-
graphic location enable proper grouping and mapping of
results. For host species, the NCBI-Taxonomy IDs [33] and
Bird Life International taxonomy (http://www.birdlife.org/
datazone/info/taxonomy) names were used as standard
terms, including the NCBI taxonomy number. For the geo-
graphical locations, two-letter ISO codes for the countries
and provinces were used (ISO-3166, 2012) [33]. This allows
for each of the host species and each geographic term to
be described in nonambiguous terms. Examples of corrected
ambiguities are shown in Table 1. The FASTA format is easily
understandable because of the descriptive nature of the fields
in the FASTA header. Finally we use the term key:yes for all
entries that could be fully annotated allowing them to be
utilized within the analysis framework of FluKB, while those
that could not be fully annotated are assignedwith key:no and
can only be found by a search.
2.5. Implementation of Analytical Tools. A set of analytical
and visualization tools have been integrated within the
FluKB. These tools include a selection of keyword searching
tools: MAFFT [14] for multiple sequence alignment (MSA)
and BLAST [13] for sequence similarity search. Specialized
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Table 1: All the alternative instances of the host Mallard in all of the
entries in the knowledge base of FluKB. The standardized name for
the search key isMallard; Anas platyrhynchos; 8839.
Alternative names for
Mallard
Number of times
present in dataset Status
Anas domesticus 1 Ambiguous
Anasplatyrhynchos 9 Error
Anasplatyrhynchos 39 Correct
Domestic duck 58 Variant
Domestic Mallard 11 Variant
Feral duck 1 Ambiguous
Khaki campbell duck 12 Variant
Mallard 25,844 Correct
Mallard duck 1,172 Redundant
Pekin duck 137 Variant
Peking duck 92 Error
Sentinel duck 13 Error
Wdk 11 Ambiguous(abbreviation)
Wild duck 952 Ambiguous
Total 28,352
tools for the analysis of variability include sequence conser-
vation metrics and their visualization using block entropy
analysis [34]. The T-cell epitope prediction tools for HLA
Class I and Class II have been integrated within FluKB for
vaccine-related analyses. WebLogo [22] and BlockLogo [23]
tools are used for visualization of results.
2.5.1. Sequence Conservation Metrics. FluKB enables conser-
vation analysis of single positions within protein sequences,
of linear blocks of amino acids extracted from multiple
sequence alignments (MSA) of proteins using block entropy
[34]. In addition, virtual peptides can be constructed from
discontinuous epitopes within MSA and can be analyzed
using block entropy, enabling the variability analysis of B-
cell epitopes [30]. All these calculations are based on the
calculation of Shannon entropy [35].
2.5.2. Visualization of Sequence Variability. WebLogo enables
fast and easy interpretation of the position specific variability
in an alignment. It displays amino acids by their correspond-
ing one-letter code on a graph where all the amino acids
present in one position are stacked on top of each other,
and the frequency in the position is then based on their
individual height in the graph. BlockLogo enables variability
analysis of peptides (either linear peptides or discontinuous
strings of amino acids), rather than single residues. The
combinatorial number of possible blocks that can be created
from a WebLogo can quickly become very large because of
variation in individual positions. BlockLogo only shows the
exact peptides that are most frequent for the investigated
positions.
2.5.3. Prediction of MHC Class I and II Binders. For class
I HLA binding prediction, the NetMHCpan 2.8a algorithm
[19] was implemented. The alleles available for predictions
are HLA-A∗02:01, -A∗03:01, -A∗11:01, -A∗2402, -B∗07:02, -
B∗08:01, and -B∗15:01, since prediction accuracies for these
alleles are relatively high [36]. Additionally, we predict
binders to HLA-A∗01:01 since this allele is of very high fre-
quency in the human population, although these predictions
are of slightly lower accuracy than the seven benchmarked
alleles. Collectively these alleles cover approximately 82% of
humanpopulation [37]. For class IIMHCpredictionsweused
NetMHCIIpan 3.0 [21], with which users can predict binders
to HLA-DRB1∗01:01, ∗03:01, ∗04:01, ∗07:01, ∗11:01, ∗13:01,
and ∗15:01, as these have been benchmarked and validated
for high accuracy [21].These alleles cover approximately 40%
of the human population [37].
2.5.4. Analysis of Sequence Similarity and Geographical Map-
ping (Strain Mapper). The standardized data mining key
in FluKB enables sequence similarity searching and the
display of a sequence’s origin on the world map. For this
purpose, we developed the specialized tool, Strain Map-
per. The query sequence is entered in the search window
and optionally the maximal number of amino acid mis-
matches can be selected. We used Google Earth software
(http://www.google.com/earth/) for geographic map display.
It is combined with sequence similarity analysis to allow user
to select a query sequence and find its closest matches in
FluKB and visualize them on the world map. This feature
provides visualization of epidemiological information useful
for evaluating the spread of a given virus and closely related
variants.
3. FluKB Database
3.1. Data Repository. The FluKB sequence repository as of
December 2014 contains 402,306 sequence entries from
75,426 unique strains of influenza. There are 67,907 type A,
7,028 type B, 194 type C, and 297 unknown type sequence
entries. Out of 330,435 full-length sequences and 71,501
fragments, 370 protein sequences failed to align well to any of
the template alignments during the annotation process. Each
sequence entry contains information about location, host,
and time of isolation, as well as a standardized nomenclature
for identification of strains. Each entry contains a protein
sequence with standardized, curated, and enriched annota-
tions (Table 2).
The epitope repository contains a total of 357 unique T-
cell epitopes (194 class I and 163 class II) and 685 unique HLA
binders (572 class I and 113 class II). Each record describes
the type of epitope (T-cell epitope, naturally processed, or
HLA binder), epitope sequence type (only exact epitopes are
included in the repository), experimental method used for
validation, HLA-restriction, and literature references.
Twenty-eight neutralizing antibodies against influenza
virus have crystal structures ofHA/antibody complexes avail-
able in PDB. The functional data and neutralizing specificity
of these antibodies were collected from published articles.
Twenty of these antibodies target the globular head of the HA
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Table 2: The data fields in each protein entry.
Field title Field content
CVC accession Accession number unique to FluKB
NCBI accession Accession number unique to NCBI
GenBank GI Accession number unique to GenBank
Type The influenza virus type
Subtype The serotype
Host Host of collection
Country Location of collection
Year Time of collection
Isolate Isolate name
Vaccine strain Years the strain has been used as avaccine strain
Original nomenclature The original nomenclature from theraw data
Protein name The protein name, based on templateBLAST
Sequence type Full or fragment of the proteinsequence
Predict HLA binders Predict HLA binders to the sequence
Blast sequence Blast the sequence for similarsequences of FluKB
Sequence The amino acid sequence of the entry
Epitopes in sequence IEDB epitopes found in the proteinsequence
protein, and the binding sites of the remaining eight antibod-
ies are located onHAstem region.All of these antibodieswere
classified as broadly neutralizing (cross neutralization within
subtype or across subtypes) and strain-specific antibodies.
We plan to have yearly updates of FluKBmoving forward
as new data and tools become available.
3.2. Data Cleaning, Quality Control, and Enrichment. The
sequence data collected from IRD were subject to extensive
cleaning, quality control (QC), and enrichment of anno-
tations. We found that 142,232 (38.25%) of the 402.306
entries contained at least one type of error, ambiguity, or
missing data. Most errors were in the geographic location
fields where 72,340 (17.9%) had an error and 6,821 (12.1%)
had missing information in the entry (see Table 3). In the
initial screen of the data we found 2,977 entries that did not
conform to nomenclature standard, including 305 entries that
lacked information about host species, 867 entries that lacked
separation fields within the nomenclature, and 1,805 other
deficiencies. These entries were manually corrected and their
nomenclatures were updated.
Furthermore, abbreviations, alternative, and misspelled
names constituted the largest proportion of errors and were
present in more than 10,000 entries. All name-related errors
were corrected by the dictionary consolidation using the
dictionary of standardized metadata terms. An example of
the redundancy is shown in Table 1 where the host “Mallard”
is found in 16,457 of the FluKB entries described by 14
different terms. In total, 96.41% of errors of various types
Table 3: The types of errors found for the geographical location in
the metadata of the entry.
Type of error Number
Case errors 26,335
Redundant information 14,165
Alternative name and abbreviations 11,208
Misspellings 2027
Alternative spellings 9,112
True location could not be determined 9493
Total 72,340
described above were corrected and 469 standardized forms
ofmissing data (such as location and host species) were added
by manually searching the original literature.
Our effort in the data cleaning and enrichment stage
focused on minimizing errors and maximizing data com-
pleteness to enhance knowledge extraction for discovery of
potential vaccine targets in influenza, as well as genetic and
epidemiological modeling of viral strains. Because of the
system of reference sequences, templates, and referenceMSA
implemented in FluKB, we expect that the majority of future
entries will be automatically corrected, if they contain errors
and redundancies already encountered by the system. Any
new errors will be subject to manual curating and updating
of dictionaries.
3.3. Standardized Nomenclature. To enable automated data
mining and workflows, we created data mining keys from the
original nomenclature of influenza viruses with standardized
terms. The data mining keys utilized NCBIs taxID database
for host species [32] and the ISO codes for geographical
location (ISO-3166, 2012) [33]. A total of 398,078 sequences
(98.95%) were assigned the new developed nomenclature,
while 4,228 (1.05%) could not be assigned. The original
standard nomenclature is included in the data mining key
as a reference for additional literature searches and text
mining of article databases [37]. Data mining for vaccine
targets often requires the analysis of subsets of data, for
example, patient data such as specific HLA profile, age group,
phenotypes, or other factors. Similarly, epidemiologicalmod-
elling may need analysis of sequences from certain hosts, for
example, specific migrating birds, or limited to geographical
locations. The host, time, and location of collection are
key information that help determine the spread of specific
influenza strains and are central for better understanding
of influenza outbreaks [38]. The data mining keys enable
such analyses by having a standardized nomenclature, which
pattern recognition algorithms can utilize as labels. Entries
without the data mining key are made unavailable to the
analysis on FluKB as inclusion of entries that lack data could
affect the reliability and the outcome of the results. The
data mining keys are furthermore nomenclature crucial for
the automation of computational analyses; standardization
of nomenclature fields allows the computer to interpret
the data automatically, which previously was limited. For
instance, the taxonomy ID of hosts enables host specific
Journal of Immunology Research 7
Table 4: The sources of the integrated tools in FluKB and URL for their stand-alone versions web services.
Tool URL Reference
BLAST http://blast.ncbi.nlm.nih.gov/Blast.cgi [11]
MAFFT MSA http://mafft.cbrc.jp/alignment/software/ [12]
NetMHCpan 2.8a http://www.cbs.dtu.dk/services/NetMHCpan/ [15]
NetMHCIIpan 3.0 http://www.cbs.dtu.dk/services/NetMHCIIpan/ [19]
Block entropy http://research4.dfci.harvard.edu/cvc/flukb/HTML/blockentropy.php ISO-3166
BlockLogo http://mafft.cbrc.jp/alignment/software/ [21]
analyses that can potentially reveal features important for
interspecies transmission of influenza. Proper organization of
data allows for grouping of data by ancestral species and the
variability can be followed over time. Furthermore the ISO
codes for the geographical location by country and provinces
enhance analyses in, for instance, epidemiological studies
where an increased resolution in terms of actual spread can
be analysed. This information can be used for the analysis of
changes in T-cell and B-cell epitopes.
4. FluKB Tools
4.1. Database Searching and Querying. In FluKB, two search
strategies can be deployed for sequence search: annotation-
based or epitope-based. The first is a keyword search that
enables the user to extract the data of FluKB into specific
subsets and the second is a sequence similarity search by
BLAST [13].These search types are vital for the following data
analysis as they enable the user to select the needed datasets
based on specific scientific questions.
4.1.1. Keyword Search. The user can query the sequence
entries for information such as the type, protein, subtype, year
range, country, province, host, original nomenclature, and
sequence type (fragment or full protein) by keyword search.
The sequence entry database is indexed in order to decrease
the retrieval time. An example of entry page retrieved by ID
FLU0306481 or Strain Name A/Guangdong/1/2013, protein
HA, is shown in Figure 3.
4.1.2. Sequence Similarity Search. FluKB has an indexed
database generated from sequence entries that can be
searched for sequence similarity using BLAST algorithm.The
standard parameters are used: 𝐸 value (10), word size (≥2),
substitutionmatrix (BLOSOM62), gap cost (11) and extension
(1), size of the result list (500), and pairwise list (250). Besides
sequence search, the FluKB entries can be searched for T-cell
epitopes and B-cell epitopes.
4.1.3. Stand-Alone Tools. FluKB can be queried using a
selection of analytical tools under the tab “Tools.” Sequence
alignment by MSA can be performed under the “Sequence
alignment” tab by entering either a list of sequence IDs in the
query window or a selection of subsets of proteins by name,
influenza type, subtype, range of years of identification, coun-
try, province, host, or complete sequences/fragments. The
protein subsets selection window (Supplemental Figure S1)
Figure 3: Record FLU0306481, Protein HA representing the 2013
H7N9 outbreak of bird flu in China.
can be used for sequence variability analysis and block
entropy calculation under appropriate tabs. Epitope block
entropy (T-cell epitopes) uses protein subsets selection win-
dow that enables the input of epitope sequence. The strain
mapping tool is described in Section 2.5.4.
4.2. Variability Analysis. The analysis of variability of viral
sequences is important for understanding the emergence
of new strains, immune escape, changes in pathogenicity,
the extent of spread of viral strains, and vaccine design.
The variability analysis can be performed interactively, but
the variability analysis tools are also integrated in the T-
cell and B-cell mapping tools and relevant workflows. The
interactive variability analysis can be performed using indi-
vidual sequences or sets of sequences. The tools used in
variability analysis are shown in Table 4. The main tools
for the analysis of variability are BLAST search that can
be accessed from individual entries (Figure 3, “find similar
sequences”) or from the “Sequence alignment” under the
“Tools” tab. The MSA can be performed from the results
of BLAST search by selection of sequences and clicking the
“Align them. . .” key. The positions of variability within the
MSA results are color-coded for better visual inspection and
each sequence is hyperlinked to its record (Supplemental
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Figure 4: T-cell epitope EPI102 and the T-cell epitope analysis from the record FLU0021633. (a) Entry EPI150 with the graphical display of
present T-cell epitope variants. (b) Graphical display of predicted T-cell epitopes (HLA-B∗07:02, length 10, IC
50
< 1000 nM).
Figure S2). The “Sequence variability analysis” tool plots
entropy (red curve) and the percentage of sequences (blue
curve) containing the consensus amino acid at all positions
along with the consensus sequence (Supplemental Figure S3).
Further visualization can be achieved by “Block entropy”
calculation, which visualizes the conservation of peptides
of lengths appropriate for immune recognition, rather than
individual residues [34]. The “Epitope block entropy” cal-
culation displays variability of a specific epitope across the
selected subset of sequences.
4.3. T-Cell Epitope Search. T-cell epitope analysis can be
performed directly from the protein entry. For example, three
T-cell epitope entries are displayed on the record entry page
(Figure 3). The epitope entry page for EPI150 is shown in
Figure 4(a). In addition, the prediction of T-cell epitopes
can be performed by selecting allele and peptide length in
the “Predicted HLA Binders” field followed by the “Submit”
action. The visual display of experimentally verified T-cell
epitopes is shown in Figure 4(b).
T-cell epitope search can also be initiated from the
“Search” tab, where epitope can be searched by the sequence.
The results will appear as a list of epitopes along with
their binding or T-cell restriction specificities. The list is
hyperlinked to the epitope record, an example of which
is shown in Figure 4(a). Finally, T-cell epitope search can
be performed using the workflow titled “Vaccine targets”
under theWorkflows tab. After selection of input parameters,
for example, Allele “HLA-A∗0201,” Protein “HA,” Influenza
type “A,” subtype “H7 N9,” year(s) “2013 2014,” Affinity
threshold “500 nM,” andConservationThreshold “95%” (and
remaining values “default”), 98 sequences will be selected and
the report will be generated.
4.4. B-Cell Epitope Search. B-cell epitope analysis can be
performed from the Search tab by selecting “Antibodies list.”
By the end of May, 2014, 28 antibodies and their detailed
neutralizing and structural information have been deposited
in FluKB. All of these antibodies are neutralizing antibodies
against hemagglutinin protein on influenza virus. These
antibodies are listed on the webpage, while their respective B-
cell epitopes can be displayed on three interactive structures:
X-31 strain-specific antibodies on HA structure from 1KEN,
broadly neutralizing antibodies on HA structure from 1EO8,
and influenza B virus antibodies onHA structure from4FQK.
This feature enables visual comparison of antibody-specific
B-cell epitopes.
For each neutralizing antibody, the isolation information,
structure information, and computational identified B-cell
epitope information can be accessed. Also, the neutralized
motifs and escape motifs extracted from experimentally
validated strains from the primary literature are presented as
well [30]. In addition, two workflows have been implemented
for further analysis: the neutralization coverage estimation
and B-cell epitope mapping (Supplemental Figure S4). The
neutralized/escape coverage by a specific existing neutral-
izing antibody is calculated for the complete population of
influenza strains. The strain population coverage by a neu-
tralizing antibody can be assessed within any selected subset
of influenza strains, such as year range, specific subtype,
and geographic coverage. The B-cell epitope mapping is per-
formed by submitting a query hemagglutinin sequence. Cross
neutralization coverage of a known neutralizing antibody can
be estimated based on sequence comparison to the known
neutralizing epitopes. A discontinuous peptide is extracted
based on epitope positions determined from crystal struc-
tures. This tentative discontinuous peptide is then compared
Journal of Immunology Research 9
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Figure 5: The results of B-cell epitope analysis II. Analysis of entry FLU0099373 for broadly neutralizing antibody F10 interaction. (a) The
BLAST result of the query sequence to the sequence with highest identity in FLUKB, (b) the discontinuous peptide extracted from the
query sequence and respective residue positions highlighted in full sequence, and (c) the summary information of neutralizing antibody.The
discontinuous peptide from the query sequence is compared to all discontinuous peptides generated from FLUKB (with their neutralizing
status listed). The identical sequence is highlighted in yellow with estimated status of neutralization given.
to the B-cell epitopes of experimentally validated strains. An
example of B-cell epitope analysis is shown in Figure 5.
FluKB offers the capability to address complex questions
relating to sequence variability on very specific subsets,
identification of potential T-cell epitopes, and selection and
combination of these epitopes into polyvalent vaccine con-
structs.Themodular structure of theworkflow renders FluKB
highly flexible. The tools and data can be reorganized and
more tools can be created to answer additional questions, for
example, relating to epidemiological modeling and analysis
of cross protective potential of neutralizing antibodies. The
overall architecture can be viewed in Supplemental Figure S5.
5. Conclusion
Publically available influenza data are a valuable resource for
computational analyses with applications in vaccine design.
Similarly, existing bioinformatics tools provide the means for
extraction of information and new knowledge. However, to
utilize the full potential of these resources, data preprocessing
must be performed and analytical tools must be carefully
combined into well-defined workflows. These workflows
allow users to ask specific questions (scientific, technical,
and clinical) and provide means for systematic data analysis.
These workflows can automatically generate comprehensive
analysis reports. The infrastructure of data and tools is the
backbone of FluKB and similar knowledge-based systems
[26, 27].
Despite many years of research and available vaccines,
influenza remains a major public health burden and a
threat of a major new pandemic. Multiple data sources
provide information on protein and nucleotide sequences
and immune epitopes in influenza [2, 5–8, 39, 40]. They
represent well-maintained catalogues of influenza sequences
and annotations, along with a selection of basic search tools.
They focus mainly on providing access to data, extraction,
and simple analyses. The FluKB was developed focusing on a
different purpose, the facilitation of datamining for influenza
vaccinology and immunology of influenza infection. The
FluKB has very clean and standardized data, integrating
information on antigen sequences, and immunological epi-
topes. The set of integrated analysis tools and workflows are
designed to aid rational vaccine design. This includes the
discovery of vaccine targets, assessment of variability, and in-
depth analysis of immune epitope. FluKB is a unique data
mining system for largely automated knowledge discovery
from the ever-increasing body of influenza data with applica-
tions in both T-cell and B-cell immunology and vaccinology.
10 Journal of Immunology Research
Systematic discovery of influenza vaccine targets requires
highly accurate, up-to-date, and standardized data of influ-
enza antigens and immune epitopes. The sequence and
epitope data available through publications, various reports,
and databases vary in quality, granularity, and data formats.
The extraction of knowledge and discovery of vaccine targets
from diverse and scattered data sources are a challenging
and time-consuming task. FluKB integrates the content
and the analytical tools in a unified system that enables
the automation of complex queries and discovery. FluKB
is a contribution to the long-standing quest for universal
influenza vaccines [41, 42] by allowing a large-scale analysis
on a large collection of annotated influenza sequences.
FluKB is publicly available at http://research4.dfci.harvard
.edu/cvc/flukb/.
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